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Objective: Although pregnant women have increased risks for
inﬂuenza morbidity and mortality, inﬂuenza vaccination rates among
pregnant women in Canada are consistently very low. This mixed-
methods study investigated the attitudes and behaviour of pregnant
women and new mothers regarding seasonal and pandemic
inﬂuenza vaccination.
Methods: We conducted a baseline survey and qualitative focus
groups with 34 women (26 pregnant women and 8 mothers of
newborns), with a follow-up survey to assess outcomes at the end
of the subsequent inﬂuenza season. Data analysis included
descriptive statistics and directed content analysis based on the
health belief model.
Results:Most women did not consider inﬂuenza vaccination to be
an important preventative measure to take while pregnant,
although some were more willing to consider vaccination
during a pandemic. Omission bias played a substantial role as
justiﬁcation for not vaccinating. Participants expressed
confusion about recommendations regarding vaccination
during pregnancy and frustration with inconsistent messages
from health care providers (HCPs), particularly with regard to
pandemic vaccines. Women were vaccinated when they
perceived themselves and/or their babies to be at increased
risk for inﬂuenza. Vaccinated women had strong normative
inﬂuences (usually an HCP or a family member) that affected
their decision. Intentions accurately predicted behaviour for
women who did and did not intend to be vaccinated.
Conclusion: Pregnant women did not perceive themselves to be
at increased risk for inﬂuenza and did not believe that
inﬂuenza vaccination was a necessary preventative health
measure. A lack of safety information about vaccination during
pregnancy and inconsistent messages from HCPs were
barriers to vaccine acceptance. Recommendations from
maternity care providers and communication about theKey Words: immunization, pregnancy, neonates, risk, mixed
methods
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would facilitate vaccine uptake.
Résumé
Objectif : Bien que les femmes enceintes courent un risque accru de
morbidité et de mortalité associées à la grippe, le taux de
vaccination antigrippale chez cette population demeure très faible
au Canada. Nous avons utilisé une méthode mixte pour évaluer les
attitudes et les comportements des femmes enceintes et des
nouvelles mères en ce qui concerne la vaccination contre la grippe
saisonnière et la grippe pandémique.
Méthodologie : Nous avons réalisé un sondage initial auprès de
34 femmes (26 femmes enceintes et 8 autres mères d’un
nouveau-né) et étudié qualitativement leur point de vue en
formant des groupes de discussion. Nous avons ensuite
effectué un sondage de suivi après la saison de la grippe.
L’analyse des données comprenait des méthodes de statistique
descriptive et une analyse des discussions dirigées reposant
sur le modèle de croyances relatives à la santé.
Résultats : Selon la plupart des femmes, la vaccination
antigrippale n’est pas une mesure de prévention importante
durant la grossesse; toutefois, certaines étaient plus enclines à
l’envisager durant une pandémie. Le refus de la vaccination
s’explique en bonne partie par le biais d’omission. Les
participantes se sont dites perdues dans les recommandations
de vaccination pendant la grossesse et frustrées par les
contradictions entre les différents fournisseurs de soins, surtout
en ce qui a trait aux vaccins antipandémiques. Les femmes qui
se sont fait vacciner l’ont fait car elles sentaient qu’elles ou leur
bébé couraient un risque accru de contracter la grippe. Les
femmes vaccinées avaient été fortement inﬂuencées par un
discours normatif (généralement celui d’un fournisseur de soins
ou d’un membre de la famille), ce qui avait joué un rôle dans
leur décision. De plus, l’intention des femmes de se faire
vacciner ou non était un excellent indicateur de leur
comportement ultérieur.
Conclusion : Les femmes enceintes ne croyaient pas qu’elles
couraient un risque accru de contracter la grippe, ni que la
vaccination antigrippale était une mesure préventive nécessaire.
Le manque de renseignements sur l’innocuité de la vaccination
pendant la grossesse et les discours contradictoires de
fournisseurs de soins ont nui à l’acceptation des vaccins. Enﬁn,
pour améliorer le taux de vaccination, il faudrait que les femmes
reçoivent des recommandations de leur prestataire de soins de
maternité et de l’information sur le risque de grippe et la gravité
de la maladie chez les femmes enceintes.NOVEMBER JOGC NOVEMBRE 2016 l 1045
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INTRODUCTION
nﬂuenza vaccination not only protects a pregnantIwoman but can provide up to six months of protection
for her newborn infant.1,2 Pregnant women are three to
four times as likely as non-pregnant women to be hospi-
talized with acute respiratory distress during inﬂuenza
season.3,4 This risk was augmented during the 2009
pandemic,5 when the rate of hospitalization for pregnant
women was four times that of the general population.
Affected pregnant women were more likely to require ICU
admission and had a higher risk for preterm delivery.6e8
The SOGC has recommended seasonal inﬂuenza vaccine
for pregnant women since 2007, including the monovalent
pandemic vaccine.9 The National Advisory Committee on
Immunization likewise recommends inﬂuenza vaccination
for pregnant women, who are identiﬁed as being “at high risk
of inﬂuenza-related complications or hospitalization.”10
Although an increased uptake of pandemic inﬂuenza vac-
cine by pregnant womenwas seen in Canada during the 2009
pandemic (ranging from 43% to 65%),11,12 rates have sub-
sequently fallen to pre-pandemic levels; Legge et al. reported
that from 2010 to 2012, less than 20% of women in Nova
Scotia who were pregnant during inﬂuenza season under-
went vaccination.13 This is in contrast to rates in the United
States, which annually approach 50%.14
Despite higher risks of inﬂuenza complications during
pregnancy and recommendations fromexperts to immunize,
pregnant women in Canada are less likely to be vaccinated
than non-pregnant women,15,16 and women do not perceive
themselves, their unborn baby, or their new infant to be at
increased risk from inﬂuenza infection.17e19 To increase
uptake of inﬂuenza vaccine among pregnant Canadian
women, it is important to understand the concerns or bar-
riers that may be preventing vaccination in this population.
Quantitative research has demonstrated that safety con-
cerns about vaccines are associated with not havingABBREVIATIONS
HBM health belief model
HCP health care provider
1046 l NOVEMBER JOGC NOVEMBRE 2016inﬂuenza vaccination, while perceived susceptibility to
inﬂuenza, perceived beneﬁts for children, and cues to ac-
tion are associated with a greater likelihood of vaccine
uptake among parents.20 In this mixed-methods study, we
sought to expand on these ﬁndings using surveys and
focus groups within a population of pregnant women and
new mothers in British Columbia who could reﬂect on
both seasonal inﬂuenza and the H1N1 pandemic.
METHODS
Participants were recruited via posters and direct approach
in waiting areas at BC Women’s Hospital in Vancouver and
at clinics afﬁliated with the University of British Columbia’s
Faculty of Medicine within the Greater Vancouver region
as well as at community perinatal support events. Of 81
potential participants, 47 (58%) declined to participate or
did not respond. Reasons for refusal included lack of in-
terest, being “too busy,” having miscarried, being in labour,
or being in ill health. The resulting sample of 34 women
was sufﬁcient to reach data saturation and to conduct our
analyses. All participants provided written informed con-
sent and received a $25 gift card. Each participant was
identiﬁed by a unique code number that was used to
identify responses in the baseline questionnaires, in focus
group transcripts, and in the follow-up Internet survey.
Demographic information and baseline information about
attitudes and behaviours regarding vaccines was collected
from all participants at study intake (immediately before
the focus group interview). Towards the end of the sub-
sequent inﬂuenza season (April to June 2011), all partici-
pants were asked to participate in an online survey to
determine whether their intention at intake regarding
vaccination predicted their subsequent behaviour and to
elicit additional information on their sources of informa-
tion about inﬂuenza vaccination and the factors which
encouraged or discouraged immunization. Twenty-two of
the 34 participants responded to the survey. Descriptive
statistics were generated for the survey variables using SAS
version 9.1 (SAS Institute Inc., Cary, NC).
Eight focus group interviews were conducted at the hospital
and afﬁliated clinics over the summer and fall of 2010, as the
North American inﬂuenza season approached. Each of the
group interviews (ﬁve with pregnant women and three with
new mothers) lasted approximately 90 minutes, and the
number of participants in each group ranged from two to
nine. A group moderator and note-taker were both present
in the interviews, and at times one of the study investigators
also observed. The group interviewswere semi-structured in
nature, with an interview guide rooted in the health belief
model21 and theory of planned behaviour22 that was
Table 1. Characteristics of pregnant women and new
mothers participating in focus groups
Characteristic N ¼ 34 %
Age group
20 to 29 years 7 20.6
30 to 39 years 24 70.6
40þ years 3 8.8
Education level
College or technical/trade 3 8.8
High school diploma 9 26.5
University degree 22 64.7
Prenatal care provider
Midwife 15 44.1
Family physician 7 20.5
Obstetrician-gynaecologist 12 35.3
Participant’s place of birth
Canada 18 52.9
Asia (Japan, China, Nepal, Philippines) 13 38.2
Europe (Russia, Scotland, France) 3 8.8
Annual household income
Under $35 000 7 20.6
$35 000 to $75 000 6 17.6
Over $75 000 15 44.1
Prefer not to answer 6 17.6
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beliefs regarding inﬂuenza vaccination, perceived severity of
and susceptibility to inﬂuenza, perceived safety of inﬂuenza
vaccination, the attitudes of friends and family towards
inﬂuenza vaccination, and the intention of individuals to be
immunized and to immunize their family. The analytic
method was directed content analysis,23 a semi-structured
approach to content analysis that uses concepts from an
existing theoretical framework as initial deductive codes,
which are then tested and expanded upon with inductive
qualitative coding. We used the HBM and theory of planned
behaviour as the theoretical bases for the focus group
questions and carried these forward to the data analysis,
focusing analysis on the components of these behavioural
models (e.g., perceived risk, perceived susceptibility, and
social norms). Focus groups were audio recorded and
transcribed for analysis using Nvivo 9 (QSR International
Americas Inc., Burlington, MA).
Ethics approval for the study was provided by the Uni-
versity of British Columbia Research Ethics Board.RESULTS
The characteristics of the 34 participants are shown in
Table 1.Most were aged 30 to 39 and had a university degree,and all but two participants were living with a partner.
Approximately half of the participants were born in Canada.
Perinatal care providers for participants were divided evenly
among midwives, obstetrician-gynaecologists, and family
physicians. The median gestational age for pregnant partic-
ipants at intake was 31 weeks (range 10 to 40), and 75% of
those with newborns (n ¼ 8) had delivered at term. The
majority of participants (64.7%, 22/34) were primigravid;
24% (8/34) had one other child, and 9% (3/34) had two.
Overall, the participants had favourable attitudes and
behaviour towards vaccines, as illustrated in the Figure. A
majority (22/34; 64.7%) completely agreed with the
statement “in general vaccines are an effective way of
protecting my health” and 79.4% (27/34) of participants
had had inﬂuenza vaccination in the past. However, when
asked if they considered vaccines to be safe for pregnant
women, only 17.6% (6/34) completely agreed and 67.6%
(23/34) somewhat agreed. Half of the women (17/34)
completely or somewhat agreed with the statement “I felt I
had enough information to make a decision about vacci-
nating myself during my pregnancy.”
Focus Group Findings
Perceptions of susceptibility to and severity of inﬂuenza
According to the HBM,21 an individual’s perceptions of
susceptibility and the severity of a health threat are major
inﬂuences on the likelihood of that person behaving in a way
to avoid the threat. We found that perceptions of suscepti-
bility and severity were important in making decisions about
maternal inﬂuenza vaccination, and that these perceptions
were weighed against the perceived risks and beneﬁts of
vaccination. In our focus groups, most participants
perceived neither themselves nor their infants to be highly
susceptible to infection. Some women compared seasonal
inﬂuenza with other perceived risks, ranking inﬂuenza as a
lesser risk. This risk assessment appeared to havemore to do
with previous public health messaging campaigns, or other
media attention to a topic, than to statistical probability
because some other risks were overestimated.
Women in the focus groups also perceived the severity of
seasonal inﬂuenza to be minor for themselves and their
infants (Table 2).
Notably, a minority of mothers did perceive themselves or
their families to be at greater risk, often due to underlying
health issues (e.g., asthma) or occupational hazards (e.g.,
nursing), and these women were highly likely to be
vaccinated.
Echoing the theme that greater media focus on a health risk
(e.g., alcohol consumption in pregnancy) resulted in greaterNOVEMBER JOGC NOVEMBRE 2016 l 1047
Figure. Attitudes towards vaccination and perceptions of risk among pregnant women and
new mothers.
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WOMEN'S HEALTHperception of susceptibility and severity; the severity of
pandemic inﬂuenza was also recognized to be greater than
seasonal inﬂuenza. Women in the focus groups reported
hearing a great deal about the H1N1 pandemic and were
“shocked” and “frightened” by reports that young women
were at greater risk of major complications and death.
Some participants were speciﬁcally concerned about an
increased risk of miscarriage and severe risks of H1N1
for their infants. Even participants who were uncon-
vinced about having seasonal inﬂuenza vaccination were
much more likely to prioritize vaccination for H1N1
pandemic inﬂuenza for themselves and their children
(Table 2).
Perceptions of the risks and beneﬁts of vaccination
Participants discussed the internal calculus they used to
weigh the risks and beneﬁts of inﬂuenza vaccination. For
most, the unknown risks from the vaccine did not
outweigh the beneﬁts of vaccination. Some were concerned
that adverse effects of vaccination might be identiﬁed years
in the future. Even during a pandemic, when many
recognized a higher susceptibility to or severity of infection,
participants felt that the risks of infection with pandemic
inﬂuenza were not greater than the unknown risks of a new
and, in their perception, untested vaccine.
Unknown risks (which might not be known for years) were
difﬁcult to weigh against potential beneﬁts and loomed1048 l NOVEMBER JOGC NOVEMBRE 2016large as barriers to obtaining inﬂuenza vaccination, espe-
cially for the H1N1 pandemic strain. As one participant
commented, comparing unknown risk with a risk that was
clearly quantiﬁable based on past evidence, “For me, the
risk that’s unknown is actually scarier.”
Participants were very concerned about vaccine in-
gredients, speciﬁcally the adjuvant added to the pandemic
inﬂuenza vaccine. They acknowledged a lack of clear
statements from health care providers and public health
ofﬁcials on this subject and found the information pro-
vided to be contradictory and confusing. This in turn
increased their concerns about the safety of the vaccine
ingredients.
The thalidomide tragedy24 spontaneously emerged as a
topic of discussion in three of the focus groups as a
cautionary example of a new drug that had been given to
pregnant women with unforeseen consequences. Although
this event occurred more than 40 years ago, it was
repeatedly presented as an example of what can happen if a
woman is not careful about what she does during
pregnancy.
Perceptions of the beneﬁts of vaccination against inﬂuenza
were diverse. For some women, vaccination in pregnancy
was a “no-brainer.” However, others perceived the beneﬁt
of vaccination to be minimal, especially compared with
other risk-mitigating activities such as wearing a seatbelt or
Table 2. Key concepts from focus groups
Concept Manifestation Example
Susceptibility to inﬂuenza Low perception of susceptibility “It’s not guaranteed that there’s a risk if you get ﬂu, as opposed to if you
drink a lot there’s guaranteed risks.”
Severity of inﬂuenza Seasonal inﬂuenza: low perception
of severity for self
“I think most people have had the seasonal ﬂu and itdyes, it’s miserable.
But you recover in two, three, four days, and you recover at home and
you don’t really need to do much else.”
Pandemic inﬂuenza: higher perception
of severity for self
“What was freaky about the last pandemic ﬂu is that people, like, normal,
healthy, you know, 30-, 40-, 50-year-old adults were getting sick and
dying because of thedthe disease was so aggressive.”
Seasonal inﬂuenza: low perception
of severity for infant
“I haven’t really heard of anything happening to babies from the ﬂu.”
Pandemic inﬂuenza: higher perception
of severity for infant
“I’m going to be getting my son the H1N1 vaccination. I was alreadydhe
has an appointment coming up. But if it, for instance, was the regular ﬂu,
I wouldn’t be getting the vaccination for him.”
Beneﬁts of vaccination High perceived beneﬁt due to known
risk of inﬂuenza for self and infant
“There’s more risk [of inﬂuenza] to me as well as my child so I want to take
that risk of protecting as opposed to not, right?”
Low perceived beneﬁt due to unknown
long-term risks to fetus or child
“They can say, ‘We’ve done studies,’ but I mean, what’s going to show up
ﬁve years from now, ten years from now?”
Values as modifying
factors
Omission bias “It’s not that you’re stopping something, like stopping drinking or whatever.
Wearing your seatbelt, I mean, you wear your seatbelt all the time. So it
doesn’t change. But this [inﬂuenza vaccination], you’re actually
ingesting something, or you’re putting something into your body, that
could somehow affect your unborn baby, right?”
Natural ideology “What doesn’t kill you makes you stronger, kind of, in certain situations,
with a caveat on that. But it’s good for your immune system to be
exposed to these pathogens, to a certain extent.”
Attitudes and Beliefs of Pregnant Women and New Mothers Regarding Inﬂuenza Vaccination in British Columbiataking prenatal vitamin supplements. The repeated com-
parison of the risks of inﬂuenza and the risks and beneﬁts
of vaccination against other more established medical
advice for pregnant women (e.g., risks of inﬂuenza versus
risks of smoking) suggested that participants felt that they
had limited time for mitigating risk, and, thus, risks needed
to be prioritized so that the most important might be
managed.
Values as modifying factors
Three values held by some participants about vaccina-
tions emerged as factors that modiﬁed women’s decisions
about inﬂuenza vaccination. The ﬁrst of these was
omission bias, or the preference for a harm caused by
inaction (e.g., non-vaccination) over a harm caused by
action (e.g., vaccination).25,26 A related second value was a
natural ideology,27 in which participants expressed a
preference for risks perceived as natural (e.g., a “home
remedy”) as opposed to those made by human science or
industry (e.g., a pharmaceutical preparation). The third
value that modiﬁed decisions about vaccination was
aversion to ambiguity26 (i.e., frustration or avoidance if
the risks of action are unclear). In some cases, these three
values may coincide; an example of this would be when
the “natural” option may be not to vaccinate and thisoption is selected in part due to perceived ambiguity of
risks and beneﬁts. However, they may also manifest
separately, such as when action is taken that is perceived
to be “natural” (e.g., use of homeopathic nosodes or
deliberate exposure to contagion). All three of these
values are known to correlate with hesitancy about vac-
cines and anti-vaccine attitudes more broadly,28e31 yet
they appeared within the focus groups of this generally
pro-vaccine sample of women (Table 2).
Omission bias in this study was entangled with the issue of
unknown risks of fetal exposure to vaccination, particularly
with the new H1N1 vaccine. However, even with seasonal
inﬂuenza vaccination, some participants described identi-
fying with the value of omission bias.
Although the study sample was generally pro-vaccine and
readily used scientiﬁc and statistical language, the natural
ideology rationale was occasionally apparent. In this
context, natural ideology bias emerged as a preference for
immunity based on experiencing illness over immunity
from a vaccine. Both omission bias and natural ideology
were intertwined with aversion to ambiguity among some
women in this sample, in that “scientiﬁc” interventions
were sometimes perceived as carrying hidden threats, even
if risks were fairly well documented.NOVEMBER JOGC NOVEMBRE 2016 l 1049
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The majority of participants (n ¼ 20) in the focus groups
believed that their HCP was a good source of information
and said that their HCP’s recommendation to be vacci-
nated against inﬂuenza would inﬂuence them to be vacci-
nated. However, only seven participants recalled receiving
information about inﬂuenza vaccination from their HCP;
others found their HCP to be neutral on the subject, and
two noted that their HCP appeared annoyed and rushed
when they asked questions about the vaccine. Although
most women did not recall their HCP ever discussing the
inﬂuenza vaccine with them, a small minority admitted to
feeling pressured by their family, their HCP, or both, to
undergo vaccination.
Survey Results: Vaccination Intentions and
Behaviours
Of the 22 women who completed the follow-up survey,
11 intended to be vaccinated at study intake, seven were
undecided, and four intended not to be vaccinated. In-
tentions accurately predicted behaviour (P ¼ 0.04) for
the four women who did not intend to be vaccinated,
none of whom reported obtaining the vaccine. In-
tentions were fairly accurate at predicting behaviour for
those who intended to be vaccinated, as 64% (7/11) did
undergo vaccination (P ¼ 0.36). Of the seven who were
undecided at intake, three were vaccinated and four were
not.
Of the 10 follow-up survey respondents who were vacci-
nated, all reported that they felt well informed about the
inﬂuenza vaccine and believed that it was safe and would
protect their baby and family. Eight reported that a health
professional had recommended inﬂuenza vaccination to
them. Among the 12 women who were not vaccinated, all
reported thinking they would not be infected with inﬂu-
enza, 42% did not feel well informed enough to make a
decision to be vaccinated, 42% were concerned about
vaccine safety, and 50% did not discuss vaccination with
their HCP.DISCUSSION
We used a mixed-method study to examine intentions and
behaviour towards inﬂuenza vaccination over time and
found that intentions accurately predicted behaviour for
those who intended not to vaccinate and moderately pre-
dicted behaviour for those who did intend to vaccinate.
Even for participants who were unsure, their behaviour
reﬂected their intentions, with some choosing to vaccinate
and others not. Feeling informed about the inﬂuenza
vaccine and having a recommendation from a health1050 l NOVEMBER JOGC NOVEMBRE 2016professional to vaccinate both correlated with being
vaccinated. However, many participants described
balancing their perceived susceptibility to inﬂuenza, the
potential severity of infection, the beneﬁts of being
immunized against perceived (and sometimes unknown)
risks of vaccination, and values that may cause bias against
medical intervention. For those who were undecided, cues
to action in the form of advice from a health professional
and clear media communication about the risks and ben-
eﬁts of inﬂuenza and the vaccine could tip the balance in
favour of vaccination.
The lack of perception of personal risk for inﬂuenza
infection and of complications during pregnancy expressed
by the majority of our participants was striking. This
occurred despite some acknowledgement that pregnant
women and young infants are at increased risk for inﬂu-
enza complications. Most pregnant women in our study did
not view themselves as personally at risk for inﬂuenza and
its complications, and most participants did not view their
unborn child or infant as being at increased risk; they also
did not think that the beneﬁts of potentially preventing
something they may not acquire exceeded the risks that a
poor decision on their part (i.e., accepting a vaccine that
later proved to be unsafe) could have on their baby. Many
expressed the belief that inﬂuenza infection was “natural”
and not something they should try to prevent, even during
pregnancy. The lack of information about the safety of
inﬂuenza vaccine during pregnancy and inconsistent mes-
sages from HCPs were barriers to vaccine acceptance.
Conﬂicting messages from the health community on vac-
cine additives, such as the adjuvanted pandemic vaccine,
created confusion and doubt, even in women who were
conﬁdent in their decision to vaccinate.
However, study participants placed a great deal of trust in
their HCPs. Although a recommendation from a HCP
did not universally lead to vaccine acceptance, the lack of
a recommendation was linked to hesitancy about vacci-
nation, and sometimes outright rejection, in our partici-
pants. Maternity care providers, including obstetricians,
family physicians, midwives, and doulas, were viewed as
credible, respected sources of information, and they
therefore have great potential to inﬂuence inﬂuenza
vaccine uptake among pregnant women. There is great
potential for these care providers to improve outcomes
for their patients by recommending vaccination and
answering questions and concerns about vaccination and
its safety.32,33
A limitation of this study is that it involved a small con-
venience sample of pregnant women and new mothers in
one urban area. As such, the ﬁndings reﬂect the attitudes
Attitudes and Beliefs of Pregnant Women and New Mothers Regarding Inﬂuenza Vaccination in British Columbiaand concerns of these women towards inﬂuenza vaccina-
tion during pregnancy, but may not be generalizable to the
broader population of pregnant women in Canada. Factors
such as recall and social desirability bias may also have
played a role in participants’ responses.
CONCLUSION
Our mixed-methods analysis of the intentions, beliefs, and
actions of pregnant women regarding inﬂuenza vaccination
suggests that many pregnant women may struggle with
weighing the risks and beneﬁts of inﬂuenza vaccination.
Improving communications about the potential severity of
inﬂuenza, the increased susceptibility to infection of
pregnant women and newborns, and the risks and beneﬁts
of vaccination could lead to increased uptake of vaccina-
tion among this at-risk population. Because maternity care
providers are highly trusted by pregnant women, we
recommend they take a more active role in such commu-
nications. Maternity care providers can have a direct in-
ﬂuence on preventing inﬂuenza infection during pregnancy
through positive and consistent messaging on the beneﬁts
of vaccination.
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